Semnur Pharmaceuticals, Inc. (SMNRW) Stock buybacks 2023–2024
Semnur Pharmaceuticals, Inc. (SMNRW) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$43.4MFY2024 · since FY2023: $40.5M → $43.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $43.4M | +7.1% |
| FY2023 | $40.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SMNRW financial trends
SMNRW RevenueSMNRW Net incomeSMNRW Net marginSMNRW Gross profitSMNRW Gross marginSMNRW Operating incomeSMNRW Operating marginSMNRW Operating cash flowSMNRW Free cash flowSMNRW Capital expendituresSMNRW Return on equitySMNRW Dividends paidSMNRW Total assetsSMNRW Total liabilitiesSMNRW Shareholders’ equitySMNRW overview →